Anne Cathrine Nøhr Jensen, PhD, is currently the Director and EA to the SVP in Medical & Translational Science at Novo Nordisk, a position they have held since 2025. They previously worked as a Consultant at McKinsey & Company from 2017 to 2019. Anne completed a PhD Fellowship at the University of Copenhagen, where they focused on the pharmacological characterization of the orphan receptor GPR139. They also gained international experience as a Visiting PhD Fellow at Universität Bonn and participated in a leadership program at McKinsey. Anne holds a Master of Science and Bachelor of Science from the University of Copenhagen, where they received top grades for their theses.
Location
Copenhagen, Denmark
This person is not in any teams